Pendal Group’s Penumbra PEN Stock Holding History

Pendal Group’s Portfolio PEN Stock Details PEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,518	Closed	-$802K	–	498
2017 Q4	$802K	Buy	+8,518	New	+$845K	0.01%	326

Other funds holding PEN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Pendal Group's PEN Position: Q1 2018 in Review

Pendal Group sold out of Penumbra (PEN) in Q1 2018, closing a stake of 8,518 shares — an estimated $802K sold.

Pendal Group first reported a position in PEN in Q4 2017 and held it in 1 quarter. The position peaked at $802K in Q4 2017. 171 funds tracked by Wall St. Rank hold PEN as of Q1 2018.

Pendal Group reported no remaining Penumbra position as of Q1 2018 after selling out during the quarter.
Pendal Group sold 8,518 Penumbra shares in Q1 2018, an estimated $802K.
Pendal Group first reported a position in Penumbra in Q4 2017 and held it in 1 quarter.
Pendal Group's Penumbra position peaked at $802K in Q4 2017.
171 funds tracked by Wall St. Rank held Penumbra as of Q1 2018.

Based on Pendal Group's 13F filing for Q1 2018, filed 8 May 2018.